Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok
BEIJING,Feb. 25,2025-- The digital cooperation between Singapore and China holds exceptional promise,given their mutual commitment to technological innovation and digital transformation. Singapore,wit
DUBAI,UAE,Feb. 25,2025-- Emirates,as the international airline based in Dubai,has announced its first series of pilot recruitment roadshows in Macao Special Administrative Region,China to meet the str
HONG KONG,Feb. 25,2025-- In the digital age,the global financial industry is undergoing rapid transformation,and Hong Kong\'s Fusion Bank has just unveiled a significant milestone in its digital infra
Strategic Growth to Strengthen International Supply Chain and Meet Rising Global Demand JOHOR BAHRU,Malaysia,Feb. 25,2025-- Paris Baguette,the globally renowned bakery brand under SPC Group,has offici
